Young girls wait to be administered with a cervical cancer vaccine HPV Gardasil, on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
A health worker administers a cervical cancer vaccine HPV Gardasil to a girl on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
A health worker administers a cervical cancer vaccine HPV Gardasil to a girl on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
A health worker administers a cervical cancer vaccine HPV Gardasil to a girl on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
A health worker administers a cervical cancer vaccine HPV Gardasil to a girl on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
A health worker prepares to administer a cervical cancer vaccine HPV Gardasil to a girl on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
A health worker shows a cervical cancer vaccine HPV Gardasil, during a vaccination campaign on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
Young girls who have been vaccinated with HPV Gardasil vaccine sit on a bench on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
A health worker administers a cervical cancer vaccine HPV Gardasil to a girl on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
Health workers arrive to administer cervical cancer vaccine HPV Gardasil to young girls on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
A health worker administers a cervical cancer vaccine HPV Gardasil to a girl on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
A health worker waits to administer a cervical cancer vaccine HPV Gardasil to young girls on the street in Ibadan,Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
A health worker administers a cervical cancer vaccine HPV Gardasil to a girl on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
Health workers talk with a girl before administering a cervical cancer vaccine HPV Gardasil to her at a health centre in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)
A health worker administers a cervical cancer vaccine HPV Gardasil to a girl on the street in Ibadan, Nigeria, on May 27, 2024. African countries have some of the world's highest rates of cervical cancer. Growing efforts to vaccinate more young girls for the human papillomavirus are challenged by the kind of vaccine hesitancy seen for some other diseases. Misinformation can include mistaken rumors that girls won't be able to have children in the future. Some religious communities must be told that the vaccine is "not ungodly." More than half of Africa's 54 nations – 28 – have introduced the vaccine in their immunization programs, but only five have reached the 90% coverage that the continent hopes to achieve by 2030. (AP Photo/Sunday Alamba)